vs

Side-by-side financial comparison of Industrial Logistics Properties Trust (ILPT) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

Industrial Logistics Properties Trust is the larger business by last-quarter revenue ($113.9M vs $75.5M, roughly 1.5× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 3.1%). Industrial Logistics Properties Trust produced more free cash flow last quarter ($42.0M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 0.7%).

Industrial Logistics Properties Trust is a real estate investment trust that owns and operates a portfolio of industrial and logistics real estate assets primarily across the United States. Its holdings include distribution centers, warehouses, and last-mile delivery properties, serving e-commerce, retail, manufacturing and supply chain operators to meet their storage and logistics operation needs.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

ILPT vs PBYI — Head-to-Head

Bigger by revenue
ILPT
ILPT
1.5× larger
ILPT
$113.9M
$75.5M
PBYI
Growing faster (revenue YoY)
PBYI
PBYI
+24.7% gap
PBYI
27.7%
3.1%
ILPT
More free cash flow
ILPT
ILPT
$27.7M more FCF
ILPT
$42.0M
$14.4M
PBYI
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
0.7%
ILPT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ILPT
ILPT
PBYI
PBYI
Revenue
$113.9M
$75.5M
Net Profit
$-1.8M
Gross Margin
69.3%
Operating Margin
-22.1%
22.7%
Net Margin
-1.6%
Revenue YoY
3.1%
27.7%
Net Profit YoY
92.6%
EPS (diluted)
$-0.02
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ILPT
ILPT
PBYI
PBYI
Q4 25
$113.9M
$75.5M
Q3 25
$110.9M
$54.5M
Q2 25
$112.1M
$52.4M
Q1 25
$111.9M
$46.0M
Q4 24
$110.5M
$59.1M
Q3 24
$108.9M
$80.5M
Q2 24
$110.6M
$47.1M
Q1 24
$112.2M
$43.8M
Net Profit
ILPT
ILPT
PBYI
PBYI
Q4 25
$-1.8M
Q3 25
$-21.6M
$8.8M
Q2 25
$-21.3M
$5.9M
Q1 25
$-21.5M
$3.0M
Q4 24
$-24.1M
Q3 24
$-25.0M
$20.3M
Q2 24
$-23.2M
$-4.5M
Q1 24
$-23.4M
$-4.8M
Gross Margin
ILPT
ILPT
PBYI
PBYI
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
Q2 24
77.4%
Q1 24
75.5%
Operating Margin
ILPT
ILPT
PBYI
PBYI
Q4 25
-22.1%
22.7%
Q3 25
-29.4%
17.6%
Q2 25
-30.8%
12.7%
Q1 25
-26.9%
8.7%
Q4 24
-31.1%
22.6%
Q3 24
-33.5%
27.4%
Q2 24
-32.4%
-4.6%
Q1 24
-31.7%
-5.3%
Net Margin
ILPT
ILPT
PBYI
PBYI
Q4 25
-1.6%
Q3 25
-19.4%
16.2%
Q2 25
-19.0%
11.2%
Q1 25
-19.2%
6.5%
Q4 24
-21.8%
Q3 24
-22.9%
25.2%
Q2 24
-20.9%
-9.6%
Q1 24
-20.9%
-11.0%
EPS (diluted)
ILPT
ILPT
PBYI
PBYI
Q4 25
$-0.02
$0.26
Q3 25
$-0.33
$0.17
Q2 25
$-0.32
$0.12
Q1 25
$-0.33
$0.06
Q4 24
$-0.37
$0.40
Q3 24
$-0.38
$0.41
Q2 24
$-0.35
$-0.09
Q1 24
$-0.36
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ILPT
ILPT
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$94.8M
$97.5M
Total DebtLower is stronger
$4.2B
$22.7M
Stockholders' EquityBook value
$489.7M
$130.3M
Total Assets
$5.2B
$216.3M
Debt / EquityLower = less leverage
8.56×
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ILPT
ILPT
PBYI
PBYI
Q4 25
$94.8M
$97.5M
Q3 25
$83.2M
$94.4M
Q2 25
$58.6M
$96.0M
Q1 25
$108.0M
$93.2M
Q4 24
$131.7M
$101.0M
Q3 24
$153.9M
$96.7M
Q2 24
$146.2M
$96.8M
Q1 24
$128.4M
$107.2M
Total Debt
ILPT
ILPT
PBYI
PBYI
Q4 25
$4.2B
$22.7M
Q3 25
$4.2B
$34.0M
Q2 25
$4.2B
$45.3M
Q1 25
$4.3B
$56.7M
Q4 24
$4.3B
$68.0M
Q3 24
$4.3B
$79.3M
Q2 24
$4.3B
$90.7M
Q1 24
$4.3B
$102.0M
Stockholders' Equity
ILPT
ILPT
PBYI
PBYI
Q4 25
$489.7M
$130.3M
Q3 25
$494.1M
$115.3M
Q2 25
$519.1M
$104.7M
Q1 25
$539.5M
$97.1M
Q4 24
$562.0M
$92.1M
Q3 24
$585.9M
$71.1M
Q2 24
$618.3M
$48.5M
Q1 24
$643.2M
$51.0M
Total Assets
ILPT
ILPT
PBYI
PBYI
Q4 25
$5.2B
$216.3M
Q3 25
$5.2B
$202.9M
Q2 25
$5.2B
$194.9M
Q1 25
$5.4B
$196.2M
Q4 24
$5.4B
$213.3M
Q3 24
$5.5B
$220.7M
Q2 24
$5.5B
$205.0M
Q1 24
$5.5B
$214.1M
Debt / Equity
ILPT
ILPT
PBYI
PBYI
Q4 25
8.56×
0.17×
Q3 25
8.49×
0.30×
Q2 25
8.09×
0.43×
Q1 25
7.96×
0.58×
Q4 24
7.65×
0.74×
Q3 24
7.35×
1.12×
Q2 24
6.96×
1.87×
Q1 24
6.70×
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ILPT
ILPT
PBYI
PBYI
Operating Cash FlowLast quarter
$60.7M
$14.4M
Free Cash FlowOCF − Capex
$42.0M
$14.4M
FCF MarginFCF / Revenue
36.9%
19.1%
Capex IntensityCapex / Revenue
16.4%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$79.8M
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ILPT
ILPT
PBYI
PBYI
Q4 25
$60.7M
$14.4M
Q3 25
$22.7M
$9.7M
Q2 25
$18.4M
$14.1M
Q1 25
$11.4M
$3.6M
Q4 24
$2.0M
$15.6M
Q3 24
$-3.4M
$11.0M
Q2 24
$10.8M
$1.0M
Q1 24
$8.0M
$11.2M
Free Cash Flow
ILPT
ILPT
PBYI
PBYI
Q4 25
$42.0M
$14.4M
Q3 25
$17.6M
$9.7M
Q2 25
$15.2M
$14.1M
Q1 25
$5.0M
$3.6M
Q4 24
$-3.7M
$15.6M
Q3 24
$-5.9M
$11.0M
Q2 24
$9.4M
$1.0M
Q1 24
$5.9M
FCF Margin
ILPT
ILPT
PBYI
PBYI
Q4 25
36.9%
19.1%
Q3 25
15.9%
17.7%
Q2 25
13.5%
26.8%
Q1 25
4.5%
7.7%
Q4 24
-3.4%
26.4%
Q3 24
-5.5%
13.7%
Q2 24
8.5%
2.1%
Q1 24
5.2%
Capex Intensity
ILPT
ILPT
PBYI
PBYI
Q4 25
16.4%
0.0%
Q3 25
4.6%
0.0%
Q2 25
2.9%
0.0%
Q1 25
5.7%
0.1%
Q4 24
5.2%
0.0%
Q3 24
2.3%
0.0%
Q2 24
1.3%
0.0%
Q1 24
1.9%
0.0%
Cash Conversion
ILPT
ILPT
PBYI
PBYI
Q4 25
Q3 25
1.10×
Q2 25
2.41×
Q1 25
1.21×
Q4 24
Q3 24
0.54×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons